Benefits outweigh risks: Health Canada lets clotting drug back on market

TORONTO - Health Canada is letting a clotting drug pulled from use several years ago back on the market. The department says a risk assessment of aprotinin, sold under the brand name Trasylol, shows that the benefits of the drug outweigh its risks....More